Working… Menu

A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03395704
Recruitment Status : Completed
First Posted : January 10, 2018
Last Update Posted : March 4, 2020
PRA Health Sciences
Information provided by (Responsible Party):
La Jolla Pharmaceutical Company

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 28, 2019
Actual Study Completion Date : October 28, 2019